5 - Contents

6-7 NEWS
EC approves Novartis’ Kymriah for blood cancer; FDA approves Alexion's Ultomiris

8-9 NEWS
Gilead signs $300m deal with Dragonfly; Sanofi's Rezurock results show positive patient outcomes

10 CORONAVIRUS NEWS
AstraZeneca and RQ Bio sign licensing agreement; WHO estimates 14.9 million excess deaths during COVID-19

12 DARWIN'S MEDICINE
Why your company may be making you less competent

13 POLICY AND PUBLIC HEALTH
Statistics from the COVID-19 pandemic

14 BRAVEHEART
Allowing ourselves to be truly innovative

15 PHARMA STRATEGIST'S BLOG
How to best prepare for launch success

16-17 DRIVING INNOVATION AND IMPROVING PATIENT OUTCOMES
Takeda’s Peter Schnack talks about the role of digital and data in pharma and how data is poised for its most propulsive role

20-21 THE MICROBIOME AS A DRUG TARGET FOR PARKINSON'S DISEASE
Subsequent research on the neurodegenerative processes associated with PD have led to the identification of new therapeutic targets and candidates, but few of these have transformed patient care

22-23 IT'S TIME TO REDEFINE HOW THE PHARMACEUTICAL INDUSTRY LOOKS AT RARE DISEASE
Why changing the standard of care for rare disease involves changing the standard of diagnosis

24-25 A COMMUNITY STUDY ON COVID-19 VACCINE SIDE EFFECTS
How community-based insights from patient registries can help us to better understand the side effects of COVID-19 vaccinations

28-29 CLOSING THE WIDENING GAP BETWEEN HCP'S EXPECTATIONS AND THEIR PHARMA EXPERIENCES
HCPs want a greater volume of educational and scientific content, so pharma companies need to revisit their existing content strategy if they want to change HCPs’ perceptions - why pharma companies should focus on increasing their share of engagement over their share of voice

30-32 A CREATIVE AWAKENING
The call is growing for creativity to be a core characteristic of every aspect of a drug’s journey – how creativity can be applied across the pharmaceutical sector

38-39 THE PATH FORWARD. HOW PHARMA CAN DRIVE FOUR KEY-HEALTHCARE TRENDS
The field of healthcare is transitioning from an old traditional model to a future model characterised by innovation

45 HEALTHCARE COMMS
'Evoke and Ashfield Health merge to form new global comms platform; Aurora launches new
Social Impact practice’

June 2022